Price T Rowe Associates Inc Lemaitre Vascular Inc Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 283,099 shares of LMAT stock, worth $25.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

283,099

Previous 279,282 1.37%

Holding current value

$25.9 Million

Previous $23 Million 14.44%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$80.3 - $92.89 $306,505 - $354,561	3,817 Added 1.37%	283,099 $26.3 Million
Q2 2024 Aug 14, 2024	BUY	$62.62 - $83.59 $17.1 Million - $22.9 Million	273,639 Added 4849.18%	279,282 $23 Million
Q1 2024 May 15, 2024	BUY	$54.0 - $71.06 $37,530 - $49,386	695 Added 14.05%	5,643 $375,000
Q4 2023 Feb 14, 2024	BUY	$45.37 - $58.41 $23,456 - $30,197	517 Added 11.67%	4,948 $281,000
Q3 2023 Nov 14, 2023	BUY	$53.45 - $67.01 $25,068 - $31,427	469 Added 11.84%	4,431 $242,000
Q2 2023 Aug 14, 2023	BUY	$50.38 - $68.21 $199,605 - $270,248	3,962 New	3,962 $267,000
Q4 2021 Feb 14, 2022	SELL	$46.66 - $56.25 $467,253 - $563,287	-10,014 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$53.09 - $60.57 $2,866 - $3,270	54 Added 0.54%	10,014 $532,000
Q2 2021 Aug 16, 2021	SELL	$47.74 - $63.33 $130,807 - $173,524	-2,740 Reduced 21.57%	9,960 $608,000
Q1 2021 May 17, 2021	SELL	$40.19 - $51.5 $723 - $927	-18 Reduced 0.14%	12,700 $620,000
Q4 2020 Feb 16, 2021	BUY	$31.44 - $41.27 $399,853 - $524,871	12,718 New	12,718 $515,000

Others Institutions Holding LMAT

# of Institutions

291

Shares Held

20.4M

Call Options Held

5.2K

Put Options Held

2.9K

View Full List

About LEMAITRE VASCULAR INC

Ticker LMAT
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 21,962,900
Market Cap $2.01B
Description
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...

More about LMAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Lemaitre Vascular Inc Transaction History